| Characteristics | Total (n=256) | NSTEMI (n=147) | STEMI (n=109) | P value |
|---|---|---|---|---|
| Age (yr) | 63.3±13.0 | 67.6±12.1 | 59.8±12.8 | <0.001 |
| Female (%) | 80 (31.3) | 56 (38.8) | 24 (21.8) | 0.004 |
| Medical history | ||||
| Diabetes mellitus | 93 (36.3) | 63 (42.9) | 30 (27.3) | 0.01 |
| Hypertension | 126 (49.2) | 85 (57.8) | 41 (37.3) | 0.001 |
| Heart failure | 46 (18.0) | 37 (25.2) | 9 (8.2) | <0.001 |
| Stroke | 25 (9.8) | 21 (14.3) | 4 (3.6) | 0.004 |
| Myocardial infarction | 40 (15.6) | 34 (23.1) | 6 (5.5) | <0.001 |
| Smoking | 120 (46.9) | 57 (39.0) | 63 (57.3) | 0.004 |
| Thrombolysis | 32 (12.5) | 5 (3.4) | 27 (25.5) | <0.001 |
| PCI | 192 (75.0) | 97 (66.7) | 95 (86.4) | <0.001 |
| CABG | 7 (2.7) | 6 (4.1) | 1 (0.9) | 0.244 |
| Hemoglobin (g/dL) | 13.4±2.3 | 12.8±2.4 | 14.2±2.0 | <0.001 |
| eGFR (mL/min/1.73 m2) | 64.2±23.8 | 60.0±25.1 | 69.9±20.8 | 0.001 |
| C-reactive protein (mg/dL) | 2.1±4.3 | 2.5±4.8 | 1.7±3.3 | 0.216 |
| Remodeling type | ||||
| Normal | 152 (59.4) | 81 (55.1) | 71 (65.1) | 0.106 |
| Concentric remodeling | 15 (5.9) | 9 (6.1) | 6 (5.5) | 0.835 |
| Eccentric hypertrophy | 75 (29.3) | 51 (34.7) | 24 (22.0) | 0.028 |
| Concentric hypertrophy | 14 (5.5) | 6 (4.1) | 8 (7.3) | 0.257 |